Your browser doesn't support javascript.
loading
Evaluation of the Nigeria national HIV rapid testing algorithm.
Iriemenam, Nnaemeka C; Mpamugo, Augustine; Ikpeazu, Akudo; Okunoye, Olumide O; Onokevbagbe, Edewede; Bassey, Orji O; Tapdiyel, Jelpe; Alagi, Matthias A; Meribe, Chidozie; Ahmed, Mukhtar L; Ikwulono, Gabriel; Aguolu, Rose; Ashefor, Gregory; Nzelu, Charles; Ehoche, Akipu; Ezra, Babatunde; Obioha, Christine; Baffa Sule, Ibrahim; Adedokun, Oluwasanmi; Mba, Nwando; Ihekweazu, Chikwe; Charurat, Manhattan; Lindsay, Brianna; Stafford, Kristen A; Ibrahim, Dalhatu; Swaminathan, Mahesh; Yufenyuy, Ernest L; Parekh, Bharat S; Adebajo, Sylvia; Abimiku, Alash'le; Okoye, McPaul I.
  • Iriemenam NC; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Mpamugo A; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria.
  • Ikpeazu A; Federal Ministry of Health, Abuja, Federal Capital Territory, Nigeria.
  • Okunoye OO; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Onokevbagbe E; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria.
  • Bassey OO; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Tapdiyel J; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Alagi MA; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Meribe C; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Ahmed ML; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Ikwulono G; Federal Ministry of Health, Abuja, Federal Capital Territory, Nigeria.
  • Aguolu R; National Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria.
  • Ashefor G; National Agency for the Control of AIDS, Abuja, Federal Capital Territory, Nigeria.
  • Nzelu C; Federal Ministry of Health, Abuja, Federal Capital Territory, Nigeria.
  • Ehoche A; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria.
  • Ezra B; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria.
  • Obioha C; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria.
  • Baffa Sule I; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria.
  • Adedokun O; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria.
  • Mba N; National Reference Laboratory, Nigeria Centers for Disease Control, Gaduwa, Federal Capital Territory, Nigeria.
  • Ihekweazu C; National Reference Laboratory, Nigeria Centers for Disease Control, Gaduwa, Federal Capital Territory, Nigeria.
  • Charurat M; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Lindsay B; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Stafford KA; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Ibrahim D; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Swaminathan M; Center for International Health, Education, and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • Yufenyuy EL; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Parekh BS; Division of Global HIV and TB, Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria.
  • Adebajo S; International Laboratory Branch, Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Abimiku A; International Laboratory Branch, Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Okoye MI; Center for International Health, Education, and Biosecurity, Maryland Global Initiatives Corporation - an affiliate of the University of Maryland, Baltimore, Federal Capital Territory, Nigeria.
PLOS Glob Public Health ; 2(11): e0001077, 2022.
Article en En | MEDLINE | ID: mdl-36962660
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article